Hormone replacement therapy and hemostasis: principles of a complex interaction

Area of Science:

• Cardiovascular Health
• Hormone Therapy Research
• Hemostasis and Thrombosis

Background:

• Postmenopausal hormone replacement therapy (HRT) is associated with reduced arterial thrombotic disease risk.
• Venous thrombosis risk appears unchanged by HRT without specific risk factors.
• Effects of various HRT preparations on cardiovascular health require further clarification.

Purpose of the Study:

• To review the interaction of steroids with the hemostatic system.
• To discuss limitations in assessing and interpreting the hemostatic system for cardiovascular disease.
• To propose a new perspective on the hemostatic system's role in cardiovascular health.

Main Methods:

• Literature review on steroid-hemostatic interactions.
• Analysis of clinical and metabolic profiles influenced by HRT.
• Discussion of assessment and interpretation challenges for hemostatic markers.

Main Results:

• HRT's impact on cardiovascular diseases varies with preparation, dose, and steroid combinations.
• Differential effects on the hemostatic system are crucial for cardiovascular outcomes.
• The hemostatic system may primarily reflect endothelial function.

Conclusions:

• The hemostatic system's role in HRT and cardiovascular disease is complex.
• Endothelial function is a key consideration when evaluating HRT's cardiovascular effects.
• Further research is needed on specific HRT formulations and their impact on hemostasis.